Chronic Obstructive News Today

the first time in its history. multiple explosions rock the southern ukrainian city of zaporizhzhia with the regional governor blaming russia. a warning that petrol prices could rise after global oil producer opec agrees it will reduce output. the british home office suspends an immigration official and former met officer after a bbc investigation reveals hed been posting racist content on whatsapp. hello if youre watching in the uk or around the world. 3a people including 23 children ...

Media Update New data presented at ATS demonstrate Sanofis leadership in advancing potential new therapies for patients with immune-mediated respiratory...

Pneumonia is a lung infection that can be caused by a bacteria or a virus. It causes inflammation of the alveoli or the air sacs of the lungs.

Based on the strength of their profitability, analyst recommendations, earnings, risk, dividends, valuation and institutional ownership. Both companies are small-cap medical companies, but SHLT is the better stock.

Regulatory approval for first patient study of first non-antibiotic macrolideREYKJAVIK, Iceland, November 14, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing therapeutics for chronic inflammatory diseases, has received regulatory approval to...

Financial pressures, everyone are seeing higher prices.- can | financial pressures, everyone are . seeing higher prices.- can you seeing higher prices. hello? can you hear us? yes. _ seeing higher prices. hello? can you hear us? yes. i _ seeing higher prices. hello? can you hear us? yes, i can. _ seeing higher prices. hello? can you hear us? yes, i can. i _ seeing higher prices. hello? can you hear us? yes, i can. ijust_ seeing higher prices. hello? can you hear us? yes, i can. ijust wondered| h...

Regulatory approval for proof of pharmacology study for the first non-antibiotic macrolideREYKJAVIK, Iceland, August 31, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has received...

First non-antibiotic macrolide to go into clinical development – targeting COPDSafety, tolerability and pharmacokinetic endpoints metPhase II planning underwayREYKJAVIK, Iceland, May 18, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modi...

REYKJAVIK, Iceland, March 24, 2022 / B3C newswire / -- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2022. EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment...

#ÚltimaHora|La Secretaría de Salud informó este viernes que en Morelos se han confirmado 42 mil 743 casos de covid-19; se han registrado cuatro mil 18...